Effects of spironolactone and fosinopril on the spontaneous and chronic ventricular arrhythmias in a rat model of myocardial infarction

Cardiology

Volumn 96, Issue 2, 2001, Pages 85-93

  Beck, Lionel ^a,c   Blanc Guillemaud, Vanessa ^a   Cherif, Ouafiya K ^a   Jover, Bernard ^b   Davy, Jean Marc ^a  

^a INSERM   (France)

^b UNIV MONTPELLIER   (France)

^c Hopital Gaston Doumergue   (France)

Author keywords

ACE inhibitors; Experimental heart failure; Holter monitoring; Spironolactone; Ventricular arrhythmias

Indexed keywords

ANTIARRHYTHMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOSINOPRIL; PLACEBO; SPIRONOLACTONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEART INFARCTION; HEART INFARCTION SIZE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HOLTER MONITORING; MALE; MEDICAL ASSESSMENT; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; REDUCTION;

ALDOSTERONE ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ARRHYTHMIA; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY, AMBULATORY; FOSINOPRIL; HEART RATE; HEART VENTRICLES; MALE; MYOCARDIAL INFARCTION; RANDOM ALLOCATION; RATS; RATS, WISTAR; SPIRONOLACTONE; TIME FACTORS; VENTRICULAR DYSFUNCTION; VENTRICULAR PREMATURE COMPLEXES;

EID: 0035216247     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000049089     Document Type: Article

References (26)

1. Cardiac failure and sudden death in the Framingham study
2. Electrophysiological remodeling in hypertrophy and heart failure
3. Experimental models of ventricular tachycardia and fibrillation caused by ischemia and infarction
4. Spontaneous arrhythmias in various models of cardiac hypertrophy and senescence of rats. A holter monitoring study
5. Trandolapril decreases prevalence of ventricular ectopic activity in middle-aged SHR
6. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction
7. Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure
8. Aldosterone escape during ACE inhibitor therapy in chronic heart failure
9. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
10. Aldosterone and antialdosterone therapy in congestive heart failure
11. Myocardial infarct size and ventricular function in rats
12. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications
13. Markedly different effects on ventricular remodeling result in a decrease in inducibility of ventricular arrhythmias
14. Postinfarction survival and inducibility of ventricular arrhythmias in the spontaneously hypertensive rat. Effects of ramipril and hydralazine
15. Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency
16. Spontaneous variability of complex ventricular arrhythmias detected by long-term electrocardiographic recording
17. A new method for evaluating antiarrhythmic drug efficacy
18. Cellular and in vivo electrophysiological effects of dronedarone in normal and post-myocardial infarcted rats
19. Cellular and ionic basis of arrhythmias in postinfarction remodeled ventricular myocardium
20. Arrhythmogenesis in experimental models of heart failure: The role of increased load
21. Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients
22. Effects of spironolactone on exercise capacity and neurohormonal factors in patients with heart failure treated with loop diuretics and angiotensin-converting enzyme inhibitor
23. Long-term treatment with trandolapril opposes cardiac remodeling and prolongs survival after myocardial infarction in rats
24. Effects of adding spiro-nolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease